Ayra Starr premiers new song on ‘A Colors Show,’ Gabrielle Union signs overall deal with BET, Tchouameni to join Real Madrid. Stay in the know with our Rave News Digest which summarizes five of the hottest global news you need to catch up on, saving you time and energy. Consider it your daily news fix.
1. Ayra Starr premieres new single ‘Ase’ on A Colors Show
Fast-rising Afrobeats sensation, Ayra Starr has premiered her new single “Ase” on A Colors Show. The performance aired on Tuesday, 7th June on A Colors Show YouTube channel. “Ase” which is the latest from the talented star has a mid-tempo beat and the subject matter touches on the Gen Z abhorrence for societal double standards and hypocrisy.
For her latest single, Ayra Starr taps into her Yoruba heritage and draws inspiration from Yoruba folk music which she blends with pop elements. The performance sees Ayra join the class of global artists such as Doja Cat, Jorja Smith, D Smoke, Flo Milli, amongst several other artists who have performed at A Colors Show.
2. Gabrielle Union signs overall deal with BET Studios
EXCLUSIVE: Gabrielle Union has signed an overall deal with BET Studios via her I’ll Have Another production company https://t.co/lIBT3DfUEy
— Deadline Hollywood (@DEADLINE) June 6, 2022
It was announced on Tuesday, June 7 that BET has inked an overall deal with Gabrielle Union’s production company, I’ll Have Another for BET Studios. The partnership will supply an increased demand for premium content from Black creators across an array of internal buyers, including Paramount+, SHOWTIME, CBS, Nickelodeon, BET+, and BET, in addition to select third-party platforms that are looking out for content from both leading and rising Black creatives.
Union launched I’ll Have Another in 2018 as a nod to her New York Times best-selling memoir “WE’RE GOING TO NEED MORE WINE.” Kian Gass heads up development and production for the company, which focuses on storytelling that is centered around marginalized communities that have specific point of views.
Congratulations to Gabby on this win!
3. South Africa: Zakes Bantwini leads SAMA28 nominations with seven nominations
Zakes Bantwini’s album ‘Ghetto King’ has earned him seven nominations. https://t.co/lBUufMrFPp
— TshisaLIVE (@TshisaLIVE) June 7, 2022
The 28th SA Music Awards (SAMA) are here, and Zakes Bantwini leads the nominees’ list for SAMA28 with seven nominations. The announcement took place on Tuesday, June 7, morning at The Garden Venue Boutique Hotel in Randburg. Zakes’ album “Ghetto King” is up for the Album of the Year, Male Artist of the Year, Best Dance Album and Best Engineered Album awards. His two songs, Imali with Karyendasoul featuring Nana Atta and Osama with Kasango, are in the running for the Best Collaboration award.
Recording Industry of SA CEO Nhlanhla Sibisi said t this year’s SAMAs attracted a record number of entries. He thanked the media industry and entertainment influencers for supporting artists and the judges who made this year’s panel possible.
4. Breakthrough for cancer treatment as US drug trial records ‘100% success’
An immunotherapy showed promising results in a small trial of rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. @ErinBurnett talks to oncologist Dr. Andrea Cercek about the trial: https://t.co/0nQwlbrY65
— CNN (@CNN) June 7, 2022
A United States (US) drug trial involving cancer patients has reportedly recorded 100% success. The patients had rectal cancer, a type of cancer that begins in the rectum, which is the lower end of the large intestine. According to a study published in the New England Journal of Medicine, the trial consisted of 12 patients, all of whom entered remission after taking “dostarlimab” over a six-month period.
Dostarlimab is an immunotherapy drug used in the treatment of endometrial cancer. It works by unmasking cancer cells, allowing the immune system to identify and destroy them. This clinical trial sought to know whether it could be effective against rectal cancer tumors. The researchers said the 12 patients received dostarlimab every three weeks for six months and the treatment was to be followed by standard chemoradiotherapy and surgery.
They, however, said six months after the patients stopped taking the medication, they recorded significant improvement. The scientists, however, noted that “longer follow-up is needed to assess the duration of response” and therefore cautioned against concluding that the cancer had been eradicated permanently.
5. Tchouameni to join Real Madrid in €100m transfer as Blancos agree deal with Monaco
Aurelién Tchouaméni to Real Madrid, here we go! Talks were at final stages yesterday night between Real and Monaco, it’s now fully agreed after final meeting for €80m plus add-ons to €100m. ⚪️🤝 #RealMadrid
Tchouaméni only wanted Real with contract until 2027 already agreed. pic.twitter.com/rCBPeEWY3r
— Fabrizio Romano (@FabrizioRomano) June 7, 2022
Real Madrid have won the race for Monaco midfielder Aurelien Tchouameni, with the highly-rated midfielder set to join the Blancos in a €100 million (£85m/$107m) deal. The talented 22-year-old has become one of the most sought-after talents in European football, with his star having been on the rise for some time.
Leading clubs from across Europe have been credited with holding an interest in his obvious potential, but it is the reigning champions of La Liga that will be benefiting from those qualities in 2022-23. It is understood that a deal for Tchouameni will tip over into nine figures including bonuses, with Real prepared to invest heavily in another shrewd addition for their present and future.
Our Week Day News Digest brings you a summary of five of the hottest news topics across the world––including celebrity news from Hollywood to Nollywood, the latest trending global headlines from American reports to top African news today, and the best sports stories in 2022.
For the latest in fashion, lifestyle and culture, follow us on Instagram @StyleRave_
— Read also